Pharmaceutical

Drug pricing regulator NPPA asks state drug controllers to submit action-taken reports by November 16 as a 30 per cent trade margin cap on 137 cancer drugs takes effect

Updated On: 13 Nov 2026 | 6:14 PM IST

The revised scheme removes the minimum sales threshold, lowers investment requirements and offers higher incentives for critical components and advanced medical devices

Updated On: 10 Nov 2026 | 10:41 PM IST

New ₹7,000 crore scheme may extend incentives to existing plants, adopt a platform-based approach and boost R&D in bulk-drug manufacturing

Updated On: 09 Nov 2026 | 11:26 PM IST

The Union Health Ministry has proposed tightening microbial contamination limits in Grade A clean areas to align India's pharmaceutical manufacturing standards with WHO guidelines

Updated On: 04 Nov 2026 | 11:09 PM IST

Hyderabad-based HRV Pharma acquires German clinical trial supplier Phatebo, which reported ₹350 crore revenue in 2025, marking its entry into Europe's finished formulations business

Updated On: 03 Nov 2026 | 6:49 PM IST

Domestic manufacturers want importers' margins included in a uniform trade margin framework for medical devices, with a pilot covering high-volume consumables such as IV sets

Updated On: 09 Oct 2026 | 7:55 PM IST

Volume growth reached 3.5 per cent, the highest in two years, while pricing rose about 6.2 per cent as most therapy segments recorded stronger demand

Updated On: 08 Oct 2026 | 6:07 PM IST

Drug regulators in Maharashtra, Karnataka and Uttar Pradesh are gathering data on price mark-ups, potentially strengthening the case for a review of trade margin rationalisation

Updated On: 06 Oct 2026 | 6:24 PM IST

The top 10 in August included Sun Pharma, Cipla, Abbott, Mankind Pharma, Torrent Pharmaceuticals, Alkem Laboratories, Intas Pharmaceuticals, Lupin, Zydus Lifesciences and Dr Reddy's Laboratories

Updated On: 21 Sep 2026 | 7:20 AM IST

Kopran share price: Average volumes on the counter more than doubled with a combined 13.12 million shares having changed hands on BSE and NSE.

Updated On: 16 Sep 2026 | 3:30 PM IST

Authorities are tracing an alleged interstate fake medicine network after a raid in Bidadi uncovered suspected counterfeit and expired drugs worth ₹5 crore

Updated On: 15 Sep 2026 | 3:11 PM IST

Pharma sector needs a supportive environment

Updated On: 09 Sep 2026 | 10:01 PM IST

Kaisha Pharma will manufacture ampoules, vials, prefilled syringes and cartridges, while targeting Indian and global pharmaceutical and biotechnology companies

Updated On: 04 Sep 2026 | 1:11 PM IST

Rubicon's share price hit a new high of ₹1,800 soaring 11 per cent on the BSE in Monday's intra-day deals amid heavy volume after reporting healthy earnings for Q1FY27.

Updated On: 17 Aug 2026 | 3:10 PM IST

GSK India aims to double revenue to ₹8,000 crore by FY30, with oncology and adult vaccines emerging as key growth drivers alongside its general-medicines portfolio

Updated On: 16 Aug 2026 | 11:19 PM IST

No deadline set for policy; non-scheduled drugs account for 82% of market, average channel markup on common dosage forms is 43%

Updated On: 07 Aug 2026 | 11:18 PM IST

India's pharma industry must pivot from global leadership in generics to innovation, backed by stronger policy, R&D funding and regulatory reforms, says Satish Reddy

Updated On: 06 Aug 2026 | 11:19 PM IST

Emcure expects overseas markets to drive growth in FY27 through product approvals, differentiated offerings and capacity expansion, while domestic business is seen improving

Updated On: 06 Aug 2026 | 7:17 PM IST

USFDA has granted final approval to Zydus Lifesciences' generic version of IC-Green, an imaging agent used in vascular, transplant and cancer surgeries.

Updated On: 04 Aug 2026 | 6:04 PM IST

Strong custom synthesis growth, peptide opportunities and higher earnings estimates support Divi's outlook, but elevated valuations could restrict further stock upside

Updated On: 03 Aug 2026 | 10:44 PM IST